Clozapine Worsens Glucose Intolerance, Nonalcoholic Fatty Liver Disease, Kidney Damage, and Retinal Injury and Increases Renal Reactive Oxygen Species Production and Chromium Loss in Obese Mice - Chang, Geng-Ruei; Liu, Hsien-Yueh; Yang, Wei-Cheng; Wang, Chao-Min; Wu, Ching-Fen; Lin, Jen-Wei; Lin, Wei-Li; Wang, Yu-Chen; Lin, Tzu-Chun; Liao, Huei-Jyuan; Hou, Po-Hsun; Chan, Chee-Hong; et al. (International Journal of Molecular Sciences, 2021)
Keywords: Adipocytes; Animals; Biomarkers; Body Weights and Measures; Chromium; chromium; clozapine; fatty liver disease; glucose intolerance; obesity; renal damage; retinal injury; reactive oxygen species; Clozapine; Diabetes; Disease Models, Animal; Dopamine; Fatty Acid-Binding Proteins; Fatty liver; Fluorescent Antibody Technique; Food; Gene Expression; Gene Expression Regulation; Glucose; Glucose Intolerance; Hyperglycemia; Immunohistochemistry; Insulin; Insulin resistance; Kidney Diseases; Kidneys; Liver; Liver diseases; Metabolism; Mice; Mice, Obese; Nitric Oxide Synthase Type II; Non-alcoholic Fatty Liver Disease; Obesity; Oxidative stress; Proto-Oncogene Proteins c-akt; Psychotropic drugs; Reactive Oxygen Species; Retinal Diseases; Schizophrenia; Serotonin; Sterol Regulatory Element Binding Protein 1